期刊文献+

天智颗粒对血管性痴呆患者认知、生活能力的疗效观察 被引量:6

Effect of Tianzhi granule in the treatment of vascular dementia patients' cognition and viability
暂未订购
导出
摘要 目的观察天智颗粒对血管性痴呆(vascular dementia,VD)患者认知、生活能力的疗效。方法实验组78例VD患者用天智颗粒治疗,对照组60例VD患者用氟桂利嗪胶囊治疗,疗程为60 d。在疗程的第1、30、60天分别采用简易精神状态检查表(MMSE)及日常生活能力量表(ADL)进行认知、生活能力的评定。结果实验组中的轻、中度患者的总有效率高于对照组(P<0.05),而在重症患者2组无明显差异;2组在疗程的第30天、第60天的MMSE评分高于、ADL评分低于疗程的第1天,且实验组评分优于对照组(P<0.05);2组在疗程的第30天、第60天的MMSE、ADL评分前后比较无统计学意义(P>0.05)。结论天智颗粒可以改善轻中度VD患者的认知、生活能力,从而提高患者的生存质量。 Objective To observe the effectiveness of Tianzhi granule in the treatment of vascular dementia(VD) patients'cognition and viability.Methods Experimental group of 78 cases were treated with the Tianzhi granule,control group of 60 cases were treated with flunarizine capsule.Treatment course was sixty days.Mini-Mental State Examination(MMSE) and activities of daily living(ADL) were used to assess vascular dementia patients'cognition and viability in the first,thirtieth,sixtieth day course of treatment.Results Total effective rate of mild and moderate patients in experimental group was higher than that in observation group(P0.05),while in critically ill patients were not significant in both groups;In two groups,MMSE score higher,ADL score in the thirtieth,sixtieth day lower than the first day of the treatment,and the situation of improvement in experimental group was better than that in control group(P0.05);but MMSE score and ADL score were not significantly different in the thirtieth,sixtieth day of treatment course(P0.05).Conclusion Tianzhi granule can improve the cognition and viability of patients who suffering with mild to moderate VD,and promote the life quality.
作者 李世泽
出处 《中国实用神经疾病杂志》 2011年第4期7-9,共3页 Chinese Journal of Practical Nervous Diseases
关键词 血管性痴呆 天智颗粒 氟桂利嗪 Tianzhi granule Vascular dementia Flunarizine
  • 相关文献

参考文献12

二级参考文献39

  • 1王鲁宁.老年人轻度认知功能障碍的研究进展[J].中华老年医学杂志,2005,24(1):6-8. 被引量:69
  • 2刘传军,李善刚,郭延奎,高慧英.缺氧缺血性脑损伤对新生大鼠大脑皮质突触发育的追踪研究[J].中国行为医学科学,2006,15(5):429-430. 被引量:17
  • 3万鸿平,章军建,汪长银.慢性脑供血不足患者的认知功能与脑血流变化[J].中国行为医学科学,2007,16(1):26-27. 被引量:27
  • 4丁克祥 钟永先 等.微量指血超氧化物歧化酶快速测定法的研究[J].老年学杂志,1987,7(2):42-42.
  • 5傅仁杰.老年呆病的诊断、辨证分型及疗效评定标准(讨论稿)[J].中医杂志,1991,(2):56-56.
  • 6盛树力.从分子生物学到临床诊治老年性痴呆[M].北京:北京科学技术文献出版社,1999.2.
  • 7中华人民共和国卫生部.中药新药治疗痴呆的临床研究指导原则[S].中药新药临床研究指导原则(下集),1995:206-209.
  • 8PETERSEN RC, DOODY A, KURZ R, et al. Current concepts inmil dc ogn itiveim paierment [ J ]. ArchN euorl, 2001,58(12) : 1985-1992.
  • 9JC Morris. The Clinical Dementia Rating (CDR): current version and scoring rules[J]. Neurology, 1993, 43 (11) : 2412-2414.
  • 10[1]Murakami Y,Zhao Q,Harada K,et al.Choto-san,a Kampo formula improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor.Pharmacol Biochem Behav,2005,81:616-625.

共引文献85

同被引文献103

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部